Epion Therapeutics is developing innovative treatments for corneal diseases with the goal of saving and improving vision for millions of patients around the world. EpiSmart, our transformative cross-linking system targeting keratoconus, a common type of corneal ectasia, is designed to be minimally invasive with reduced discomfort and a significantly reduced recovery time versus current standards of care.
Epion's elegant approach will elevate the standard of care by enabling the treatment of both eyes simultaneously and eliminating the need for further deterioration.
With a true epi-on approach that does not disrupt the epithelium, Epion is striving to deliver safer and more accessible vision-preserving care to millions of patients globally.
Company Details
- Employees
- 12
- Address
- 1500 District Ave, Burlington,ma 01803,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.epiontx.com/
- HQ
- Burlington, MA
Epion Therapeutics Questions
Epion Therapeutics's website is https://www.epiontx.com/
Epion Therapeutics's LinkedIn profile is https://www.linkedin.com/company/epiontx
Epion Therapeutics has
12 employees.
View email and phone details for 12
employees at Epion Therapeutics.
Epion Therapeutics's industry is
Pharmaceutical Manufacturing
Epion Therapeutics's top competitors are
Avisi Technologies,
Istar Medical,
Maculaser Ltd,
Azalea Vision,
Eyetronic,
Zilia,
Recornea,
Bionic Vision Technologies,
Beyeonicsโข Vision,
Revision Implant.
Epion Therapeutics's categories are Pharmaceutical Manufacturing
